Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery (Q41121484)

27 September 2017

Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

27 September 2017

0 references

0 references

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

inferred from title

author name string

Palanivelu Praveenraj

1

1 reference

27 September 2017

Rachel M Gomes

2

1 reference

27 September 2017

Saravana Kumar

3

1 reference

27 September 2017

Purushothaman Karthikeyan

4

1 reference

27 September 2017

Annapoorni Shankar

5

1 reference

27 September 2017

Ramakrishnan Parthasarathi

6

1 reference

27 September 2017

Palanisamy Senthilnathan

7

1 reference

27 September 2017

Subbiah Rajapandian

8

1 reference

27 September 2017

Chinnusamy Palanivelu

9

1 reference

27 September 2017

language of work or name

1 reference

3 April 2015

1 reference

27 September 2017

1 reference

27 September 2017

25

1 reference

27 September 2017

11

1 reference

27 September 2017

2078-2087

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-015-1655-1

27 September 2017

0 references

cites work

Bariatric surgery worldwide 2003.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Metabolic/bariatric surgery worldwide 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Nonalcoholic fatty liver disease in India - a lot done, yet more required!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-015-1655-1

Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

12 December 2020

Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery

1 reference

12 December 2020

Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.

1 reference

12 December 2020

Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis.

1 reference

12 December 2020

The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West

1 reference

12 December 2020

Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery

1 reference

12 December 2020

Prevalence of non-alcoholic fatty liver disease: population based study.

1 reference

12 December 2020

Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.

1 reference

12 December 2020

Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease

1 reference

12 December 2020

Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery

1 reference

12 December 2020

World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

1 reference

12 December 2020

Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease

1 reference

12 December 2020

10.1007/S11695-015-1655-1

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

0 references

1 reference